TGFB1 and glioma: Here, we first characterized the expression landscape of a panel of immune stimulatory and immunosuppressive checkpoint molecules in murine glioma cell lines as well as in syngeneic immune cells and explored the potential impact of a key immunosuppressive mediator, TGF-β, on the expression of these molecules.